Gene-based therapies in patients with critical limb ischemia

References

• Nehler MR, Duval S, Diao L, et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014 Sep;60(3):686-95.e2.
   PubMed Web of Science ®Google Scholar
• Albers M, Fratezi AC, de Luccia N. Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. J Vasc Surg. 1992 Jul;16(1):54–59.
   PubMed Web of Science ®Google Scholar
• Davies MG. Critical limb ischemia: introduction. Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):2.
   PubMedGoogle Scholar
• Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Transatlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006 Mar 21;47(6):1239–1312.
   PubMed Web of Science ®Google Scholar
• Mehler PS, Coll JR, Estacio R, et al. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003 Feb 11;107(5):753–756.
   PubMed Web of Science ®Google Scholar
• Jaff MR, White CJ, Hiatt WR, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): the TASC steering committee. Catheterization and cardiovascular interventions. Catheter Cardiovasc Interv. 2015 Oct;86(4):611–625.
   PubMed Web of Science ®Google Scholar
• Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005 Dec 3;366(9501):1925–1934.
   PubMed Web of Science ®Google Scholar
• Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010 May;51(5Suppl):18S–31S.
   PubMedGoogle Scholar
• Spiliopoulos S, Kitrou P, Christeas N, et al. Starclose SE(R) hemostasis after 6F direct antegrade superficial femoral artery access distal to the femoral head for peripheral endovascular procedures in obese patients. Diagn Interv Radiol. 2016 Nov-Dec;22(6):542–547.
   PubMed Web of Science ®Google Scholar
• Kitrou P, Parthipun A, Diamantopoulos A, et al. Paclitaxel-coated balloons for failing peripheral bypass grafts: the BYPACS study. J Cardiovasc Surg (Torino). 2014 Apr;55(2):217–224.
   PubMed Web of Science ®Google Scholar
• Siablis D, Kitrou PM, Spiliopoulos S, et al. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial. JACC Cardiovasc Interv. 2014 Sep;7(9):1048–1056.
   PubMed Web of Science ®Google Scholar
• Katsanos K, Kitrou P, Spiliopoulos S, et al. Comparative effectiveness of plain balloon angioplasty, bare metal stents, drug-coated balloons, and drug-eluting stents for the treatment of infrapopliteal artery disease: systematic review and Bayesian network meta-analysis of randomized controlled trials. J Endovasc Ther. 2016 Dec;23(6):851–863.
   PubMed Web of Science ®Google Scholar
• Katsanos K, Spiliopoulos S, Karunanithy N, et al. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. J Vasc Surg. 2014 Apr;59(4):1123-1133.e8.
   PubMed Web of Science ®Google Scholar
• Kitrou P, Spiliopoulos S, Karnabatidis D, et al. Cutting balloons, covered stents and paclitaxel-coated balloons for the treatment of dysfunctional dialysis access. Expert Rev Med Devices. 2016 Dec;13(12):1119–1126.
   PubMed Web of Science ®Google Scholar
• Spiliopoulos S, Kitrou P, Katsanos K, et al. Current phase II drugs under investigation for the treatment of limb ischemia. Expert Opin Investig Drugs. 2015;24(11):1447–1458.
   PubMed Web of Science ®Google Scholar
• Makinen K, Manninen H, Hedman M, et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther: J Am Soc Gene Ther. 2002 Jul;6(1):127–133.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Mohler ER 3rd, Lederman RJ, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 2003 Oct 21;108(16):1933–1938.
   PubMed Web of Science ®Google Scholar
• Kusumanto YH, van Weel V, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther. 2006 Jun;17(6):683–691.
   PubMed Web of Science ®Google Scholar
• Powell RJ, Simons M, Mendelsohn FO, et al. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation. 2008 Jul 01;118(1):58–65.
   PubMed Web of Science ®Google Scholar
• Powell RJ, Goodney P, Mendelsohn FO, et al. Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial. J Vasc Surg. 2010 Dec;52(6):1525–1530.
   PubMed Web of Science ®Google Scholar
• Nikol S, Baumgartner I, van Belle E, et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther: J Am Soc Gene Ther. 2008 May;16(5):972–978.
   PubMed Web of Science ®Google Scholar
• Belch J, Hiatt WR, Baumgartner I, et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet. 2011 Jun 04;377(9781):1929–1937.
   PubMed Web of Science ®Google Scholar
• Creager MA, Olin JW, Belch JJ, et al. Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation. 2011 Oct 18;124(16):1765–1773.
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003 Jun;9(6):653–660.
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995 Jan;1(1):27–31.
   PubMed Web of Science ®Google Scholar
• Simons M. Angiogenesis: where do we stand now? Circulation. 2005 Mar 29;111(12):1556–1566.
   PubMed Web of Science ®Google Scholar
• Helisch A, Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation. 2003 Jan;10(1):83–97.
   PubMed Web of Science ®Google Scholar
• de Muinck ED, Simons M. Re-evaluating therapeutic neovascularization. J Mol Cell Cardiol. 2004 Jan;36(1):25–32.
   PubMed Web of Science ®Google Scholar
• Luttun A, Carmeliet P. De novo vasculogenesis in the heart. Cardiovasc Res. 2003 May 1;58(2):378–389.
   PubMed Web of Science ®Google Scholar
• Bobek V, Taltynov O, Pinterova D, et al. Gene therapy of the ischemic lower limb–Therapeutic angiogenesis. Vascul Pharmacol. 2006 Jun;44(6):395–405.
   PubMed Web of Science ®Google Scholar
• Baumgartner I, Chronos N, Comerota A, et al. Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia. Mol Ther: J Am Soc Gene Ther. 2009 May;17(5):914–921.
   PubMed Web of Science ®Google Scholar
• Mac Gabhann F, Qutub AA, Annex BH, et al. Systems biology of pro-angiogenic therapies targeting the VEGF system. Wiley Interdiscip Rev Syst Biol Med. 2010 Nov-Dec;2(6):694–707.
   PubMed Web of Science ®Google Scholar
• Mac Gabhann F, Annex BH, Popel AS. Gene therapy from the perspective of systems biology. Curr Opin Mol Ther. 2010 Oct;12(5):570–577.
   PubMedGoogle Scholar
• Morishita R, Nakamura S, Hayashi S, et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension. 1999 Jun;33(6):1379–1384.
   PubMed Web of Science ®Google Scholar
• Hayashi S, Morishita R, Nakamura S, et al. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells. Circulation. 1999 Nov 9;100(19 Suppl):II301–8.
   PubMedGoogle Scholar
• Kaga T, Kawano H, Sakaguchi M, et al. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor. Vascul Pharmacol. 2012 Aug 19;57(1):3–9.
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985). 2000 Apr;88(4):1474–1480.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998 Jul 30;394(6692):485–490.
   PubMed Web of Science ®Google Scholar
• Sarkar K, Fox-Talbot K, Steenbergen C, et al. Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18769–18774.
   PubMed Web of Science ®Google Scholar
• Vincent KA, Shyu KG, Luo Y, et al. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation. 2000 Oct 31;102(18):2255–2261.
   PubMed Web of Science ®Google Scholar
• Hiasa K, Ishibashi M, Ohtani K, et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation. 2004 May 25;109(20):2454–2461.
   PubMed Web of Science ®Google Scholar
• Kibbe MR, Ajay Y, Rajiv P, et al. Abstract 19419: A phase IIa randomized double-blind, placebo controlled study to evaluate plasmid stromal cell-derived factor-1 for treatment of critical limb ischemia - The STOP-CLI trial. Circulation. 2014;130:A19419.
   Google Scholar
• Cuende N, Rico L, Herrera C. Concise review: bone marrow mononuclear cells for the treatment of ischemic syndromes: medicinal product or cell transplantation? Stem Cells Transl Med. 2012 May;1(5):403–408.
   PubMed Web of Science ®Google Scholar
• Teraa M, Sprengers RW, Schutgens REG, et al. Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trial. Circulation. 2015 Mar 10;131(10):851–860.
   PubMed Web of Science ®Google Scholar
• Caplan AI. Molecular and cellular differentiation of muscle, cartilage, and bone in the developing limb. Prog Clin Biol Res. 1986;217B:307–318.
   PubMedGoogle Scholar
• Piersma AH, Brockbank KG, Ploemacher RE, et al. Characterization of fibroblastic stromal cells from murine bone marrow. Exp Hematol. 1985 May;13(4):237–243.
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007 Jul;25(7):1737–1745.
   PubMed Web of Science ®Google Scholar
• Yurugi-Kobayashi T, Itoh H, Yamashita J, et al. Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage. Blood. 2003 Apr 1;101(7):2675–2678.
   PubMed Web of Science ®Google Scholar
• Narazaki G, Uosaki H, Teranishi M, et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation. 2008 Jul 29;118(5):498–506.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Shibata R, Kito T, et al. Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells. BMC Cell Biol. 2010 Sep 22;11:72.
   PubMed Web of Science ®Google Scholar
• Lederman RJ, Mendelsohn FO, Anderson RD, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet. 2002 Jun 15;359(9323):2053–2058.
   PubMed Web of Science ®Google Scholar
• Grines CL, Watkins MW, Helmer G, et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 2002 Mar 19;105(11):1291–1297.
   PubMed Web of Science ®Google Scholar
• Sanada F, Taniyama Y, Kanbara Y, et al. Gene therapy in peripheral artery disease. Expert Opin Biol Ther. 2015 Mar;15(3):381–390.
   PubMed Web of Science ®Google Scholar
• Gudmundsson G, Matthiasson SE, Arason H, et al. Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am J Hum Genet. 2002 Mar;70(3):586–592.
   PubMed Web of Science ®Google Scholar
• Murabito JM, White CC, Kavousi M, et al. Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genetics. 2012 Feb 1;5(1):100–112.
   PubMed Web of Science ®Google Scholar
• Kotchey NM, Adachi K, Zahid M, et al. A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction. Mol Ther: J Am Soc Gene Ther. 2011 Jun;19(6):1079–1089.
   PubMed Web of Science ®Google Scholar
• Hernandez YJ, Wang J, Kearns WG, et al. Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model. J Virol. 1999 Oct;73(10):8549–8558.
   PubMed Web of Science ®Google Scholar
• Kumagai M, Marui A, Tabata Y, et al. Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia. Heart Vessels. 2016 May;31(5):713–721.
   PubMed Web of Science ®Google Scholar
• Castle J, Feinstein SB. Ultrasound-directed, site-specific gene delivery. Methods Mol Biol. 2014;1141:67–76.
   PubMedGoogle Scholar
• Tu C, Das S, Baker AB, et al. Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia. ACS Nano. 2015;9(4):3436–3452.
   PubMed Web of Science ®Google Scholar
• Thom R, Rowe GC, Jang C, et al. Hypoxic induction of vascular endothelial growth factor (VEGF) and angiogenesis in muscle by truncated peroxisome proliferator-activated receptor gamma coactivator (PGC)-1alpha. J Biol Chem. 2014 Mar 28;289(13):8810–8817.
   PubMed Web of Science ®Google Scholar
• Rowe GC, Raghuram S, Jang C, et al. PGC-1alpha induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Circ Res. 2014 Aug 15;115(5):504–517.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Ding S, Wu J, et al. Norepinephrine stimulates mobilization of endothelial progenitor cells after limb ischemia. PLoS One. 2014;9(7):e101774.
   PubMed Web of Science ®Google Scholar